Sign In
Buy BLU
$14.74
+0 (+0%)
At Close: Sep 27, 2023
Bellus Health shareholders say yes to US$2B GSK takeover
10:04am, Monday, 19'th Jun 2023
BELLUS Health Inc (TSX:BLU) said its shareholders overwhelmingly have approved a US$2 billion takeover by GSK PLC (LSE:GSK, NYSE:GSK). The late-stage biopharmaceutical firm said in a statement that al
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
01:50pm, Friday, 16'th Jun 2023
MONTREAL--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“BELLUS” or the “Company”) today announced the positive outcome of the BELLUS shareholders (“Shareholders”) vote a
Alliance Entertainment Reports Third Quarter and Nine Month Fiscal 2023 Financial Results
05:26pm, Monday, 22'nd May 2023
PLANTATION, Fla.--(BUSINESS WIRE)--Alliance Entertainment Holding Corporation (OTC: AENT) (“Alliance Entertainment”, “Company”), a distributor and wholesaler of the world’s largest in stock
BELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSK
05:01pm, Tuesday, 16'th May 2023
MONTRÉAL--(BUSINESS WIRE)--BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU.TO) (« BELLUS » ou la « société ») a annoncé aujourd’hui que la Cour supérieure du Québec a rendu une ordonnance prov
BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition
05:01pm, Tuesday, 16'th May 2023
MONTREAL--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU.TO) (“BELLUS” or the “Company”) today announced that the Superior Court of Québec has issued an interim order authorizing,
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
04:01pm, Friday, 12'th May 2023
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company working to better the lives of patients
BELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023
04:01pm, Friday, 12'th May 2023
LAVAL, Québec--(BUSINESS WIRE)--BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU) (« BELLUS Santé » ou la « société »), une société biopharmaceutique au stade clinique qui se consacre à l’amé
Tommy Hilfiger, Mercedes-AMG PETRONAS Formula One Team e Awake NY lanciano una collaborazione al Grand Prix di Miami
01:57pm, Thursday, 04'th May 2023
AMSTERDAM--(BUSINESS WIRE)--Tommy Hilfiger, marchio di proprietà di PVH Corp. [NYSE: PVH], annuncia assieme a Mercedes-AMG PETRONAS Formula One Team che il marchio newyorkese di streetwear Awake NY h
Crackle Connex Showcases Its Unique Advertising and Media Offering at IAB Newfronts
04:00pm, Wednesday, 03'rd May 2023
NEW YORK--(BUSINESS WIRE)--Crackle Connex, Chicken Soup for the Soul Entertainment’s (NASDAQ: CSSE) advertising sales division, today presented at the Interactive Advertising Bureau (IAB) Newfronts
The St. Joe Company Announces the Opening of the 255-suite Embassy Suites by Hilton Panama City Beach Resort
04:16pm, Thursday, 27'th Apr 2023
PANAMA CITY BEACH, Fla.--(BUSINESS WIRE)--The St. Joe Company (NYSE: JOE) (“St. Joe”), joint venture partner Key International, Inc. (“Key International”) and Hilton (NYSE: HLT) announce the o
BELLUS Santé annonce de l’information récente au sujet de l’assemblée
06:00pm, Wednesday, 26'th Apr 2023
LAVAL, Québec--(BUSINESS WIRE)--BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU) (« BELLUS Santé » ou la « société »), une société biopharmaceutique au stade clinique qui se consacre à l’amé
BELLUS Health Announces Meeting Updates
06:00pm, Wednesday, 26'th Apr 2023
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company working to better the lives of patients
Was This Acquisition a Savvy Play by This Big Pharma Stock?
09:00am, Wednesday, 26'th Apr 2023
U.K.-based GSK is buying Canadian biotech Bellus Health for $2 billion. The purchase will include a promising drug candidate for treating chronic cough.
Why Shares of Bellus Health Skyrocketed This Week
02:36pm, Thursday, 20'th Apr 2023
Bellus' lead therapy, camlipixant, is being tested against refractory chronic cough. The company is a clinical-stage biotech with no marketed therapies.
Bellus Health (BLU) Stock Up 99% on $2B Buyout Offer From GSK
11:29am, Wednesday, 19'th Apr 2023
Bellus Health (BLU) gets an offer to be acquired by pharma bigwig, GSK for an approximate total equity value of $2 billion. The stock is up 99%, following the news.
